Holen Sie sich die Stockscreener-App
3.22
7.33%
0.22
Handel nachbörslich:
3.22
Schlusskurs vom Vortag:
$3.00
Offen:
$3.04
24-Stunden-Volumen:
1.37M
Relative Volume:
2.17
Marktkapitalisierung:
$224.12M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-2.1467
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-15.71%
1M Leistung:
-17.22%
6M Leistung:
-41.98%
1J Leistung:
-50.08%
1-Tages-Spanne:
$2.97
$3.29
1-Wochen-Bereich:
$2.515
$3.88
52-Wochen-Spanne:
$2.515
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.22 | 211.12M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
nCino, C3.ai, Five9, Health Catalyst, and RingCentral Shares Are Soaring, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price - simplywall.st
Health Catalyst extends slide as Citi adds to downgrades after Q2 miss - MSN
C3.ai, Health Catalyst, Wix, Jamf, and ON24 Shares Are Soaring, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2025 Earnings Call Transcript - Insider Monkey
Will Health Catalyst Inc. Hold Gains Into CloseTrade Ready Stock Watch for Short Term Published - beatles.ru
Health Catalyst stock slides as Citi downgrades (HCAT:NASDAQ) - Seeking Alpha
Health Catalyst Q2 2025 Results: Revenue On Target, Outlook WeakNews and Statistics - IndexBox
Wells Fargo lowers Health Catalyst PT to $6 from $10. - AInvest
HCAT Q2 Deep Dive: Medicaid Cuts Pressure Guidance, Profitability Initiatives Take Center Stage - TradingView
Citigroup Downgrades Health Catalyst to Neutral From Buy, Adjusts Price Target to $3.50 From $6.50 - MarketScreener
Health Catalyst stock drops as Wells Fargo cuts price target on client shifts - Investing.com India
Wells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ Rating - MSN
Slammed 30% Health Catalyst, Inc. (NASDAQ:HCAT) Screens Well Here But There Might Be A Catch - 富途牛牛
Health Catalyst Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Health Catalyst Q2 2025 Earnings Call Highlights: Revenue Exceeds Guidance, Restructuring Efforts Underway - AInvest
Citigroup Downgrades Health Catalyst to Neutral with New PT of $3.5. - AInvest
Health Catalyst Shares Fall After 2025 Revenue Guidance Cut, CEO to Step Down in June 2026 - 富途牛牛
Health Catalyst (HCAT): Navigating Medicaid Cuts and Strategic Restructuring to Unlock Long-Term Value - AInvest
Health Catalyst HCAT Stock Drops 21.5% on Weak Revenue GuidanceNews and Statistics - IndexBox
Why Health Catalyst (HCAT) Stock Is Down Today - Yahoo Finance
Health Catalyst's Leadership Transition and Financial Outlook: Navigating Short-Term Volatility for Long-Term Resilience - AInvest
Health Catalyst tanks after FY revenue outlook cut, Cantor downgrade - Seeking Alpha
Earnings call transcript: Health Catalyst Q2 2025 results show significant EPS miss - Investing.com
Health Catalyst stock downgraded by Cantor Fitzgerald amid revenue concerns - Investing.com Nigeria
Health Catalyst Inc (HCAT) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Funding ... - Yahoo Finance
Health Catalyst Inc (HCAT) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Funding ... By GuruFocus - Investing.com Canada
Health Catalyst Reports Strong Q2 2025 Results - TipRanks
Health Catalyst Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Health Catalyst, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Health Catalyst: Q2 Earnings Snapshot - San Antonio Express-News
Longtime Health Catalyst CEO to step down - Modern Healthcare
Health Catalyst earnings missed by $0.63, revenue topped estimates - Investing.com Canada
Health Catalyst (NASDAQ:HCAT) Posts Q2 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Health Catalyst CEO Dan Burton to step down effective June 2026 - TipRanks
Health Catalyst CEO Dan Burton to step down in June 2026 - Investing.com Australia
Health Catalyst reports Q2 adjusted EPS 4c, consensus 4c - TipRanks
Health Catalyst CEO Retirement Announcement - TipRanks
Health Catalyst CEO Exits at Peak: 1,100 Clients, $2.2B in Healthcare Improvements - Stock Titan
Health Catalyst Reports Second Quarter 2025 Results - The Manila Times
Health Catalyst, Inc. shares fall 3.14% intraday amid mixed earnings reports from Catalyst Pharmaceuticals, Inc. - AInvest
Health Catalyst Announces Q2 2025 Operating Results and Conference Call for August 7, 2025 - AInvest
Health Catalyst Financial Results Announcement: What to ExpectNews and Statistics - IndexBox
Health Catalyst Q2 Earnings Preview: Revenue Expected to Grow 6.2% YoY, Adjusted Earnings at $0.04 per Share. - AInvest
Health Catalyst (HCAT) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Health Catalyst HCAT 2025Q2 Earnings Preview Upside Potential with Projected Revenue Growth - AInvest
Unity, Domo, Five9, Health Catalyst, and Shopify Shares Skyrocket, What You Need To Know - MSN
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt? - simplywall.st
Why is Health Catalyst Inc. stock attracting strong analyst attentionFind the best stocks for sustainable growth - Jammu Links News
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):